João Ferreira Guerra
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
João Ferreira Guerra has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- João Magalhães Pina
ULS São José, Portugal
2 shared publications - Luís Campos Pinheiro
Hospital de Sao Jose, Centro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal
2 shared publications - Miguel Lança
National Reference Laboratory for Influenza and Other Respiratory Viruses, National Institute of Health Doutor Ricardo Jorge, Portugal; NOVA Medical School, Faculdade de Ciências Médicas, Universidade NOVA de Lisboa, Lisboa, Portugal
2 shared publications - Vanessa Andrade
Hospital de Sao Jose, Centro Hospitalar e Universitário de Lisboa Central, Lisbon, Portugal
2 shared publications
Latest Publications
- Open Access
- 5 October 2024
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 4(84),p. 17-22
Renal carcinoma associated with end-stage kidney disease: A case series from a tertiary Portuguese hospital
End-stage kidney disease (ESKD) is associated with a higher incidence of renal cell carcinoma (RCC). Here we report a case series of 56 patients with ESKD who underwent radical nephrectomy for suspected renal masses at a tertiary hospital in Portugal from January 2017 to January 2024. Patient records were reviewed retrospectively to collect clinical, surgical, and pathological data. Among these patients, 12 had benign tumors, while 44 were diagnosed with malignant tumors, accounting for approximately 78.5% of the cohort. The histological analysis revealed the following distribution: clear cell RCC (20 cases, 45%), papillary RCC (11 cases, 25%), ACKD-associated RCC (6 cases, 14%), clear cell papillary RCC (4 cases, 9%), and chromophobe RCC (3 cases, 7%). Notably, the majority of patients (95.5%) had stage I malignant tumors, yet the prognosis for patients with ESKD was poorer compared to non-ESKD patients, with 7 patients succumbing during the follow-up period. This study underscores the complex relationship between ESKD and RCC, highlighting the challenges in diagnosis and management. Despite regular monitoring leading to early detection of tumors, the overall prognosis remains adversely affected by the compromised immune status and comorbid conditions prevalent in this population. The findings call for enhanced surveillance and personalized management strategies for RCC in patients with ESKD.
- 5 October 2024
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 4(84),p. 17-22
Open AccessRenal carcinoma associated with end-stage kidney disease: A case series from a tertiary Portuguese hospital
End-stage kidney disease (ESKD) is associated with a higher incidence of renal cell carcinoma (RCC). Here we report a case series of 56 patients with ESKD who underwent radical nephrectomy for suspected renal masses at a tertiary hospital in Portugal from January 2017 to January 2024. Patient records were reviewed retrospectively to collect clinical, surgical, and pathological data. Among these patients, 12 had benign tumors, while 44 were diagnosed with malignant tumors, accounting for approximately 78.5% of the cohort. The histological analysis revealed the following distribution: clear cell RCC (20 cases, 45%), papillary RCC (11 cases, 25%), ACKD-associated RCC (6 cases, 14%), clear cell papillary RCC (4 cases, 9%), and chromophobe RCC (3 cases, 7%). Notably, the majority of patients (95.5%) had stage I malignant tumors, yet the prognosis for patients with ESKD was poorer compared to non-ESKD patients, with 7 patients succumbing during the follow-up period. This study underscores the complex relationship between ESKD and RCC, highlighting the challenges in diagnosis and management. Despite regular monitoring leading to early detection of tumors, the overall prognosis remains adversely affected by the compromised immune status and comorbid conditions prevalent in this population. The findings call for enhanced surveillance and personalized management strategies for RCC in patients with ESKD.
- Open Access
- 5 August 2024
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 3(83),p. 3-7
Unraveling Zinner Syndrome: Insights from a distinct case
Zinner Syndrome (ZS) is a rare congenital malformation characterized by a triad of unilateral renal agenesis, ipsilateral seminal vesicle cyst, and ejaculatory duct obstruction. Typically discovered incidentally in the second to fourth decades of life, it presents with varied symptoms, including lower urinary tract symptoms, painful ejaculation, hemospermia, perineal pain, and infertility in 45% of cases. This article describes the case of ZS, highlighting the diagnostic and management approaches. Diagnosis relies on imaging techniques: ultrasound for initial assessment, computed tomography (CT) for detailed anatomical information and magnetic resonance imaging (MRI) as the gold standard for its superior soft-tissue contrast. Treatment depends on symptom severity and cyst size, ranging from conservative management for asymptomatic patients to surgical intervention for symptomatic cases. The primary surgical treatment involves the removal of the seminal vesicle cysts, which can effectively relieve symptoms such as pain, urinary discomfort, and ejaculatory dysfunction, thereby significantly enhancing the patient's quality of life. Minimally invasive laparoscopic or robotic surgery is preferred for its reduced morbidity and shorter recovery time. Infertility management includes surgical relief of ejaculatory duct obstruction and assisted reproductive technologies when necessary. Regular follow-up is essential for monitoring recurrences. Future research should focus on long-term outcomes and standardized management protocols to improve patient quality of life.
- 5 August 2024
- Published by Institute of Nephrology of the National Academy of Medical Sciences in Ukrainian Journal of Nephrology and Dialysis
- No. 3(83),p. 3-7
Open AccessUnraveling Zinner Syndrome: Insights from a distinct case
Zinner Syndrome (ZS) is a rare congenital malformation characterized by a triad of unilateral renal agenesis, ipsilateral seminal vesicle cyst, and ejaculatory duct obstruction. Typically discovered incidentally in the second to fourth decades of life, it presents with varied symptoms, including lower urinary tract symptoms, painful ejaculation, hemospermia, perineal pain, and infertility in 45% of cases. This article describes the case of ZS, highlighting the diagnostic and management approaches. Diagnosis relies on imaging techniques: ultrasound for initial assessment, computed tomography (CT) for detailed anatomical information and magnetic resonance imaging (MRI) as the gold standard for its superior soft-tissue contrast. Treatment depends on symptom severity and cyst size, ranging from conservative management for asymptomatic patients to surgical intervention for symptomatic cases. The primary surgical treatment involves the removal of the seminal vesicle cysts, which can effectively relieve symptoms such as pain, urinary discomfort, and ejaculatory dysfunction, thereby significantly enhancing the patient's quality of life. Minimally invasive laparoscopic or robotic surgery is preferred for its reduced morbidity and shorter recovery time. Infertility management includes surgical relief of ejaculatory duct obstruction and assisted reproductive technologies when necessary. Regular follow-up is essential for monitoring recurrences. Future research should focus on long-term outcomes and standardized management protocols to improve patient quality of life.